Objective: Substance use is a gradually increasing public health problem. Viruses such as hepatitis B, C, and HIV can be transmitted with intravenous substance cause significant morbidity mortality. Therefore, we aimed to evaluate the HIV, syphilis test results of patients followed at Şanlıurfa Alcohol Drug Addiction Research Treatment Training Center (AMATEM) clinic. Methods: The age, gender, ...

Abstract Hepatic steatosis is a frequent pathological finding in patients with chronic viral C infection (HCV) and can be independently associated increased alcohol consumption, type 2 diabetes, obesity hyperlipidemia. All these factors lead to the development of hepatic HCV. There are several noninvasive techniques scores used for diagnosing quantifying liver steatosis. Successful eradication ...

Hepatitis C virus (HCV) infection is the most common cause of chronic liver disease in world and evaluation epidemiology HCV was made possible by development a serological assay to detect antibodies epitopes HCV. Hemodialysis (HD) considered be one main risk factors transmission. The prevalence (anti-HCV) patients undergoing maintenance dialysis therapy (MDT) found highest among different group...

C 型肝炎ウイルス（HCV）感染透析患者は非感染患者より予後不良であるとされており，HCV 感染の予防・診断・治療は重要な課題である．そこで2020 年に血液透析患者のHCV の保有，検査，治療などの現状に関するアンケートを，千葉県内の透析医療機関に行った．HCV 抗体陽性者は3.7％，HCV-RNA 検査陽性者は1.7％であり，2018 年の全国調査（5.2％，2.5％）より低率であった．肝臓専門医紹介率は41％で同全国調査（22.8％）より高い傾向にあった．抗ウイルス治療はHCV 抗体陽性者の24％に行われており，そのうち71％の患者が直接作用型抗ウイルス薬による治療であった．肝臓癌の治療は過去5 年間にHCV 抗体陽性者の7.5％で行われていた．千葉県内では全国調査結果に比べHCV 感染について高い関心を持ち検査，治療が行われているがまだ改善の余地があると考えられ，より一層の疾...

Introduction: The substance misuse epidemic has fueled an increase in hepatitis C virus (HCV) infections. Despite the availability of sensitive screening and curative treatment, relatively few people are aware their diagnosis engaged care. In this study, we aimed to identify local gaps HCV care inform strategies for improvement.

Background: The clinical significance of antiphospholipid antibodies in patients with chronic hepatitis C virus (HCV) and some other viral infections is controversial. Objective: To study the prevalence of anticardiolipin antibody (ACLA) and antibeta2glycoproteinI antibody (antibeta2GPI antibody) in HCV and hepatitis B virus (HBV) infected patients and its association with liver clinical parame...

BACKGROUND: According to the most recent Egyptian demographic health census, estimated Hepatitis C virus (HCV) prevalence in 15–59 age range was 14.7%. Globally, incidence of renal impairment HCV-positive individuals is 40% higher than HCV-negative patients. HCV-induced can from mild-to-severe, and it frequently complicates treatment outcome HCV infection. AIM: This study aimed explore changes ...